Insulin resistance is a common underlying feature of T2DM and obesity which manifests from decreased insulin-stimulated glucose secretion and metabolism, and impaired suppression of hepatic glucose production as well as contribution from the gut microbiota [13,14]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.